EDITOR'S DESK

6 Factors To Consider When Adopting mHealth For Clinical Trials

From patient recruitment and retention to expedited data collection, new technologies are poised to simplify trials, create a better patient experience, and hopefully bring down the high cost of trials.

More From The Editor

CLINICAL PERSPECTIVES

  • The Similarities Between Spring Peepers & Patient Advocates
    The Similarities Between Spring Peepers & Patient Advocates

    For anyone who lives in the Northeastern region of the US, the first sound of the spring peepers is a truly joyous moment that happens each spring. For me, hearing the stories and experiences of patients who participate in clinical research is just like hearing the peepers – it’s a reminder of what is really important and why.

  • Regularizing Regulatory Requirements In Clinical Research: 25 years Of Harmonization And The Path Forward
    Regularizing Regulatory Requirements In Clinical Research: 25 years Of Harmonization And The Path Forward

    The European Community was the birthplace of regulatory harmonization. Efforts at standardizing regulatory requirements date back to the 1980s. These efforts were encouraged by the rapid increase in regulatory controls developed in the 1960s and 1970s in response to notable tragedies, such as that with thalidomide in Europe in the 1960s. The early experience in Europe showed that harmonization could be achieved, leading eventually to multiregional discussions involving Europe, Japan, and the U.S. under the early auspices of the World Health Organization (WHO).

  • Overview Of EHR Systems In BRIC Nations
    Overview Of EHR Systems In BRIC Nations

    Electronic health records (EHR) have replaced paper-based health records by more than 80 percent in established markets and up to 40 percent in emerging markets. EHRs act as a working instrument for physicians to significantly reduce 25 to 30 percent of time spent on paper work and allows patient access information.

More Clinical Perspectives

FROM THE INDUSTRY EXPERTS

  • Urinary Biomarkers Of Drug-Induced Nephrotoxicity
    Urinary Biomarkers Of Drug-Induced Nephrotoxicity

    Nephrotoxicity is a major reason for safety-related failures in drug development, often causing drugs to be withdrawn during late stages (phase2/3) of clinical development or even post-marketing. By Kamala K.Maddali, D.V.M., Ph.D., Harvey W. Kaufman, M.D., MBA, FCAP

More From The Industry Experts

WHITE PAPERS AND CASE STUDIES

  • Biosimilars In Emerging Markets Is It A Level Playing Field?
    Biosimilars In Emerging Markets Is It A Level Playing Field?

    It’s a chilling fact: One irresponsible company could seriously damage, or even destroy the biosimilar field. A single company cutting corners with under-regulated, lower-quality development could create an inferior product that harms or kills patients.

More White Papers & Case Studies

FEATURED SERVICES AND PRODUCTS

  • Specimen Collection Kit Production
    Specimen Collection Kit Production

    Marken can assist you in providing everything needed to ensure that specimens are collected properly and efficiently.

  • Clinical Study Patient Engage Services
    Clinical Study Patient Engage Services

    We believe that patient engagement is an essential component to every clinical study. We work with our clients to create a customized communication plan for each study which combines patient profiling (demographics, location and condition-specific drivers) with critical study parameters.

  • CAPA Management
    CAPA Management

    Successful businesses need to gain control over their CAPA processes to avoid regulatory sanctions and gain improvements in process performance through a streamlined and automated CAPA Management Program.

  • Late Phase Services
    Late Phase Services

    The success of a new product is judged by more than its promising clinical trial results. It needs to achieve its commercial objectives to justify initial investment. Chiltern Late Phase has focus in both local, national studies and large global programs. For example, Chiltern is currently performing registries from 100 patients to over 20,000 patients in a global setting.

     

  • Cardiovascular Clinical Research
    Cardiovascular Clinical Research

    At Worldwide Clinical Trials you benefit from outstanding expertise in the field of cardiovascular research. Our global cardiovascular team incorporates experience in the practice of cardiology, advanced scientific research with novel chemical entities and more than 20 years of conducting complex global cardiovascular clinical studies.

  • Adaptive Trial Design
    Adaptive Trial Design

    Reducing Costs and Improving Efficiency in Clinical Development.

    Adaptive trial designs offer significant benefits for biopharmaceutical companies looking to reduce costs and streamline the drug development process, increasing efficiency and success rates for their clinical programs. Adaptive trials use accumulating trial data with a prospective design to determine how to change aspects of a study, while maintaining study validity and integrity.

  • World Courier Achieves Coveted GxP-Compliant Status Worldwide With Focus On GDP, Quality Management
    World Courier Achieves Coveted GxP-Compliant Status Worldwide With Focus On GDP, Quality Management

    For over 40 years, World Courier has set the standard for worldwide time- and temperature-sensitive transportation services to the pharmaceutical industry. By World Courier

  • Drug Supply Management and Allocation
    Drug Supply Management and Allocation

    Reduce clinical trial supply wastage. Meet deliverables on time and within budget.

More Featured Services & Products

ABOUT CLINICAL LEADER

Welcome to Clinical Leader, the premier online community that helps streamline clinical research by connecting trial sponsors and cutting edge service providers. Clinical Leader is part of the Life Science Connect media group. The vision of Life Science Leader and Life Science Connect is to help facilitate connections and foster collaborations in pharmaceutical and medical device development to find ways to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute.

Visitors are enriched with valuable information on CRO, Pre-Clinical Contract Research Organization, Bio-Analytical Contract Research Organization, Clinical Contract Research Organization, Pharmacovigilance, Clinical Data Management, Electronic Patient Reported Outcomes (ePRO), Point-of-Care Testing (POCT), Patient Recruitment, Electronic Data Capture (EDC), Clinical Trials Management Systems (CTMS) and more that can improve your business and make it more profitable.

Please take a moment to join our community and discover the benefits of your free membership.

Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.

PREMIER SERVICE PROVIDER

CLINICAL LEADER WEBINARS

  • World Courier Biomedical Seminar 2015

    The World Courier Biomedical Seminar is the global conference where pharmaceutical, research and regulatory leaders receive insight on the dynamic industry — and the impact on global specialty transport. You’ll collaborate with industry thought leaders to surface new and innovative ways to solve business challenges.

  • Leverage Your EDC Solution to Mitigate Risk in Clinical Research

    Every clinical trial is built upon a study protocol - the cornerstone of any trial. A well-defined and written study protocol provides the blueprint for the study, defining its purpose and goals.

  • New FDA Guidance On Regulatory Submissions in Electronic Format

    In December 2014, FDA released the finalized Guidance for Industry “Providing Regulatory Submissions in Electronic Format—Standardized Study Data.” In this webinar, Rob Woolson and Ben Vaughn will review key points in the guidance followed by a discussion of the implications for Sponsors currently conducting studies as well as those who will be starting new studies soon.

  • Advancing Research In Skin Biology with Metabolomics

    This 30-minute webinar demonstrates how metabolomics can be a powerful tool in dermatological and skincare research.

More From Clinical Leader Webinar

FIND A CRO IN SOUTHERN CALIFORNIA

find a cro in drug development

Find a CRO with BIOCOM’s drug development guide which provides a description of each phase along with a list of companies that can accommodate your needs in the drug development cycle.

Get more info...

 UPCOMING TRAINING COURSES

Vendor Qualification and Compliance: What Sponsors & CMOs Must Know

April 21, 2015
1pm-2:30pm EDT, Online Training

Using Social Media for Patient Recruitment in Clinical Trials

April 22, 2015
1pm-2:30pm EDT, Online Training

Communication With FDA: What Do We Say And How Do We Say It?

April 28, 2015
1pm-2:30pm EDT, Online Training

Clinical Finance: Key Strategies to Stay in Control of Your Study Budget

April 29, 2015
1pm-2:30pm EDT, Online Training
More Upcoming Courses

CLINICAL BULLETIN BOARD

According to the WHO, over 150m people worldwide, are chronically infected with HCV, with 3 to 4m new infections occurring each year. Together they represent a multibillion dollar market for any successful new drug candidate, with Hepatitis C having the most promising products in development.

 CLINICAL EVENTS

Vendor Qualification and Compliance: What Sponsors & CMOs Must Know

April 21, 2015
1pm-2:30pm EDT, Online Training

Using Social Media for Patient Recruitment in Clinical Trials

April 22, 2015
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Introductory Rate

IIR's Partnering with Central Labs Summit

April 22, 2015
Boston, MA

Root Cause Analysis & CAPA Identification: A Step-by-Step Guide for Manufacturers

April 23, 2015
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate
More Events....